Inhibitory effect of oatmeal extract oligomer on vasoactive intestinal peptide-induced inflammation in surviving human skin

International Journal of Tissue Reactions

Volumn 25, Issue 2, 2003, Pages 41-46

  Boisnic, S ^a,b   Branchet Gumila, M C ^b   Coutanceau, C ^c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Grp de Rech en Dermatol/Cosmetol   (France)

^c INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

Neurogenic inflammation; Organ culture of human skin; Vasoactive intestinal peptide; Vasodilation

Indexed keywords

AVOINE RHEALBA; EOSIN; HEMATOXYLIN; OATMEAL EXTRACT OLIGOMER; OLIGOMER; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; CULTURE MEDIUM; CYTOKINE RELEASE; DERMIS; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INCUBATION TIME; INHIBITION KINETICS; MORPHOMETRICS; OAT; PLASTIC SURGERY; QUANTITATIVE ANALYSIS; SKIN CULTURE; SKIN EDEMA; SKIN INFLAMMATION; STAINING; SUPERNATANT; SURVIVAL; VASODILATATION;

ADULT; AVENA SATIVA; DERMATITIS; EDEMA; FEMALE; HUMANS; MIDDLE AGED; ORGAN CULTURE TECHNIQUES; PHYTOTHERAPY; PLANT EXTRACTS; SKIN; TUMOR NECROSIS FACTOR-ALPHA; VASOACTIVE INTESTINAL PEPTIDE; VASODILATION;

EID: 0141718843     PISSN: 02500868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Branchet-Gumila MC., Boisnic S., Le Charpentier Y., et al. Neurogenic modifications induced by substance P in an organ culture of human skin. Skin Pharmacol. Appl. Skin Physiol., 12, 211, 1999.
2. Boisnic S., Branchet-Gumila M.C., Segard C. Inhibitory effect of Avène spring water on vasoactive intestinal peptide-induced inflammation in surviving human skin. Int. J. Tissue React., 23, 89, 2001.
3. Eedy D.J. Neuropeptides in skin. Br. J. Dermatol., 128, 597, 1993.
4. Fantini F., Magnoni C., Pincelli C., Giannetti A. Neurogenic inflammation and the skin: Neural modulation of cutaneous inflammatory reactions. Eur. J. Dermatol., 5, 349, 1995.
5. Pincelli C., Fantini F., Giannetti A. Neuropeptides and skin inflammation. Dermatology, 187, 3153, 1993.
6. Lotti T., Hautmann G., Panconesi E. Neuropeptides in skin. J. Am. Dermatol., 33, 482, 1995.
7. Lundberg J.M., Hökfelt T., Anggard A. Neuropeptides with vascular activity: VIP, PHI, NPY and substance P. Bibl. Cardiol., 38, 60, 1984
8. Eedy D.J., Shaw C., Armstrong E.P. Vasoactive intestinal peptide (VIP) and peptide histidine methionine (PHM) in human eccrine sweat glands: Demonstration of innervation, specific binding sites and presence in secretions. Br. J. Dermatol., 123, 65, 1990.
9. Park Y.M., Kim C.W. The effects of substance P and vasoactive intestinal peptide on interleukin-6 synthesis in cultured human fibroblasts. J. Dermatol. Sci., 22 (1), 17, 1999.
10. Boisnic S., Branchet-Gumila M.C., Benslama L., Le Charpentier Y., Arnaud-Battandier J. Efficacy of a hydroxy acid-containing cream on long term organ culture of human nonstimulated skin. Eur. J. Dermatol., 7, 271, 1997.
11. Lotz M., Vaughan JH., Carson D.A. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science, 241, 1218, 1988.
12. Kakurai M., Fujita N., Murata S., Furukawa Y., Demitsu T., Nakagawa H. Vasoactive intestinal peptide regulates its receptor expression and functions of human keratinocytes via type I vasoactive intestinal peptide receptors. J. Invest. Dermatol., 116, 743, 2001.
13. Nikkels-Tassoudji N., Nikkels A.F., Pierard G.E. Neuropeptides cutanés. Nouv. Dermatol., 13, 767, 1994.
14. Misery L. Neuro-immuno-cutaneous system. Pathol. Biol., 10, 867, 1996.
15. Misery L. La peau neuronale, les nerfs à fleur de peau. In: Rossant L. (Ed.) "Collection Vivre et Comprendre." Ellipse, Paris, 2000.